Skip to main content
Clinical Trials/CTRI/2020/07/026469
CTRI/2020/07/026469
Completed
Phase 4

Validation of a rapid diagnostic test for the detection of COVID-19 antibodies

HealthCubed India Pvt Ltd0 sites100 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
HealthCubed India Pvt Ltd
Enrollment
100
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
July 18, 2020
Last Updated
4 years ago
Study Type
Pms

Investigators

Sponsor
HealthCubed India Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • Negative SARS\-CoV\-2 subjects:
  • Aged 18 years of age or over
  • Negative SARS\-CoV\-2 result by RT\-PCR
  • Positive SARS\-CoV\-2 subjects:
  • Aged 18 years of age or over
  • Positive SARS\-CoV\-2 result by RT\-PCR
  • Requires hospitalisation
  • 10 days post onset of symptoms

Exclusion Criteria

  • Negative SARS\-CoV\-2:
  • Aged less than 18 years
  • Outpatients
  • History of known immune suppression
  • Participation in any other trial
  • Positive SARS\-CoV\-2:
  • Aged less than 18 years
  • Patients unlikely to survive \>28 days in view of attending medical team
  • Outpatients
  • Anticipated transfer to another hospital within 72 hours

Outcomes

Primary Outcomes

Not specified

Similar Trials